Live feed
·
PRReleasevia Quantisnow
Intensity Therapeutics Inc. logo
Portage Biotech Inc. logo

Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Intensity Therapeutics Inc. logo
INTS
Intensity Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Listed since
2023
Get push alerts for INTS

Follow INTS and get a push notification the moment its next story breaks.

Full INTS profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INTS (Intensity Therapeutics Inc.), PRTG (Portage Biotech Inc.) and more on Quantisnow.